SeraCare
Krystyna Nahlik is a seasoned professional in the field of clinical genomics and molecular biology, currently serving as Commercial Manager for Clinical Genomics at LGC Clinical Diagnostics since June 2023. With a strong background in field application science, Krystyna leads a team at SeraCare, where responsibilities include driving the adoption of NGS reference materials for various clinical applications, as well as providing education and support for customers and distributors. Prior roles include serving as a Remote Genomics Support Scientist at Agilent Technologies, where technical support and training were central, and as a Research Fellow at Queen's University Belfast, focusing on myeloproliferative diseases. Krystyna holds a PhD in Molecular Biology from The University of Göttingen and an MSc in Biology from Jagiellonian University, complementing a career that spans academic research and practical applications in genomics.
This person is not in any offices
SeraCare
SeraCare, part of LGC's Clinical Diagnostics Division, enables the promise of precision medicine by advancing the understanding of disease and providing assurance of the diagnostic result. Our innovative tools and technologies not only ensure the safe, effective, and accurate performance of diagnostic assays but also establish a framework for regulating, compiling, and interpreting data from precision diagnostics. Our portfolio includes a broad range of products such as quality control technologies, disease-state specimens and tissues for research and development, processed biological materials, and immunoassay reagents.